Author:
Hirata Makoto,Sasaki Masato,Cairns Rob A.,Inoue Satoshi,Puviindran Vijitha,Li Wanda Y.,Snow Bryan E.,Jones Lisa D.,Wei Qingxia,Sato Shingo,Tang Yuning J.,Nadesan Puviindran,Rockel Jason,Whetstone Heather,Poon Raymond,Weng Angela,Gross Stefan,Straley Kimberly,Gliser Camelia,Xu Yingxia,Wunder Jay,Mak Tak W.,Alman Benjamin A.
Abstract
Enchondromas are benign cartilage tumors and precursors to malignant chondrosarcomas. Somatic mutations in the isocitrate dehydrogenase genes (IDH1 and IDH2) are present in the majority of these tumor types. How these mutations cause enchondromas is unclear. Here, we identified the spectrum of IDH mutations in human enchondromas and chondrosarcomas and studied their effects in mice. A broad range of mutations was identified, including the previously unreported IDH1-R132Q mutation. These mutations harbored enzymatic activity to catalyze α-ketoglutarate to d-2-hydroxyglutarate (d-2HG). Mice expressing Idh1-R132Q in one allele in cells expressing type 2 collagen showed a disordered growth plate, with persistence of type X-expressing chondrocytes. Chondrocyte cell cultures from these animals or controls showed that there was an increase in proliferation and expression of genes characteristic of hypertrophic chondrocytes with expression of Idh1-R132Q or 2HG treatment. Col2a1-Cre;Idh1-R132Q mutant knock-in mice (mutant allele expressed in chondrocytes) did not survive after the neonatal stage. Col2a1-Cre/ERT2;Idh1-R132 mutant conditional knock-in mice, in which Cre was induced by tamoxifen after weaning, developed multiple enchondroma-like lesions. Taken together, these data show that mutant IDH or d-2HG causes persistence of chondrocytes, giving rise to rests of growth-plate cells that persist in the bone as enchondromas.
Funder
HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Gouvernement du Canada | Canadian Institutes of Health Research
Publisher
Proceedings of the National Academy of Sciences
Reference39 articles.
1. Prevalence of shoulder enchondromas on routine MR imaging
2. Incidental Enchondromas of the Knee
3. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets
4. Levesque J Bell RS Marx R Wunder JS University of Toronto Division of Orthopaedic Surgery (1996) A Guide to Orthopaedic Tumors (Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto), p 132
5. The malignant potential of enchondromatosis;Schwartz;J Bone Joint Surg Am,1987